2015
IWISH 2015 Proceeding
New Treatment strategies for diabetes-related cognitive decline in global healthcare
Authors: Vera Novak
Abstract
The epidemic of type 2 diabetes (T2DM) is spreading around the globe and challenging the unprecedented success of health sciences in increasing longevity. T2DM has been linked to accelerated brain aging and functional decline in older adults and dementia. Intranasal insulin (INI) therapy has emerged as a potential new treatment for T2DM-related cognitive decline. Insulin resistance and glycemic variability are potential mechanisms underlying T2DM-related brain damage. Wearable technologies now allow better monitoring of behaviors and glycemic levels over several days, and may be used in the future to deliver real time feedback and new therapies for T2DM complications.
I3M Scientific Sponsors
I3M Industrial Sponsors
I3M Media Sponsors
